Notice2023-00408
Advisory Committee to the Director, Centers for Disease Control and Prevention
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 11, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This meeting is open to the public. The meeting will be webcast live via the World Wide Web.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 7 (Wednesday, January 11, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Pages 1583-1584]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-00408]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0001]
Advisory Committee to the Director, Centers for Disease Control
and Prevention
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Advisory Committee to the
Director, Centers for Disease Control and Prevention (ACD, CDC). This
meeting is open to the public. The meeting will be webcast live via the
World Wide Web.
DATES: The meeting will be held on February 7, 2023, from 10 a.m. to
3:30 p.m., EST (times subject to change). The public may submit written
comments on or before January 27, 2023.
ADDRESSES: Information for accessing the webcast will be available at
<a href="https://www.cdc.gov/about/advisory-committee-director/">https://www.cdc.gov/about/advisory-committee-director/</a>.
Written comments: You may submit comments, identified by Docket No.
CDC-2023-0001, by any of the following methods. Do not submit comments
for the docket by email. CDC does not accept comments for the docket by
email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Kerry Caudwell, DPA, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-
4027. Attn: Docket number CDC-2023-0001.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Written public comments submitted up to 72 hours prior to the ACD
meeting will be provided to ACD members before the meeting. Written
comments received in advance of the meeting will be included in the
official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, DPA, Office of the
[[Page 1584]]
Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone:
(404) 639-0390; Email Address: <a href="/cdn-cgi/l/email-protection#0f4e4c4b667d6a6c7b607d4f6c6b6c21686079"><span class="__cf_email__" data-cfemail="632220270a110600170c11230007004d040c15">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director (ACD), CDC, shall
advise the Secretary, HHS, and the Director, CDC, on policy and broad
strategies that will enable CDC to fulfill its mission of protecting
health through health promotion, prevention, and preparedness. The
committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters To Be Considered: The agenda will include discussions on
CDC's current work and priorities as they relate to health equity and
data and surveillance recommendations to the Department of Health and
Human Services and CDC Director. The agenda also includes a laboratory
workgroup update with recommended action steps to the full ACD
Committee, along with an update on the public health infrastructure
grant. Agenda items are subject to change as priorities dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-00408 Filed 1-10-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 11, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.